Alterity Therapeutics (ASX:ATH) - Webinar Presentation Company Presentations by Finance News Network March 13, 2023 10:20 AM Dr David Stamler, CEO - Alterity Therapeutics is a clinical stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases.
